Emylcamate
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Emylcamate
- DrugBank Accession Number
- DB13572
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 145.202
Monoisotopic: 145.110278727 - Chemical Formula
- C7H15NO2
- Synonyms
- Emylcamate
- External IDs
- KABI-925
- MK-250
- NSC-169882
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your software1,2-Benzodiazepine The risk or severity of CNS depression can be increased when 1,2-Benzodiazepine is combined with Emylcamate. Acetazolamide The risk or severity of CNS depression can be increased when Acetazolamide is combined with Emylcamate. Acetophenazine The risk or severity of CNS depression can be increased when Acetophenazine is combined with Emylcamate. Agomelatine The risk or severity of CNS depression can be increased when Agomelatine is combined with Emylcamate. Alfentanil The risk or severity of CNS depression can be increased when Alfentanil is combined with Emylcamate. - Food Interactions
- Not Available
Categories
- ATC Codes
- N05BC03 — Emylcamate
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as carbamate esters. These are compounds containing an ester of carbamic acid with the general structure R2NC(=O)OR' (R' not H). They are esters of carbamic acids.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Amino acids, peptides, and analogues
- Direct Parent
- Carbamate esters
- Alternative Parents
- Organic carbonic acids and derivatives / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Aliphatic acyclic compound / Carbamic acid ester / Carbonic acid derivative / Carbonyl group / Hydrocarbon derivative / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- KCJ747D3R4
- CAS number
- 78-28-4
- InChI Key
- SLWGJZPKHAXZQL-UHFFFAOYSA-N
- InChI
- InChI=1S/C7H15NO2/c1-4-7(3,5-2)10-6(8)9/h4-5H2,1-3H3,(H2,8,9)
- IUPAC Name
- 3-methylpentan-3-yl carbamate
- SMILES
- CCC(C)(CC)OC(N)=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 6278
- ChEBI
- 134769
- ChEMBL
- CHEMBL2104208
- ZINC
- ZINC000000001350
- Wikipedia
- Emylcamate
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 8.38 mg/mL ALOGPS logP 1.66 ALOGPS logP 1.69 Chemaxon logS -1.2 ALOGPS pKa (Strongest Acidic) 15.93 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 52.32 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 38.94 m3·mol-1 Chemaxon Polarizability 16.06 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 133.5146533 predictedDarkChem Lite v0.1.0 [M-H]- 135.29149 predictedDeepCCS 1.0 (2019) [M+H]+ 132.9506533 predictedDarkChem Lite v0.1.0 [M+H]+ 137.70073 predictedDeepCCS 1.0 (2019) [M+Na]+ 133.8018533 predictedDarkChem Lite v0.1.0 [M+Na]+ 146.69633 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:44 / Updated at February 21, 2021 18:54